Revvity Signals was first-to-market with SaaS software and integrates AI to help empower scientists. Read our interview with...

In 2024, Signals ChemDraw, Signals Clinical and Signals Synergy launched. Read how Revvity Signals supports new modalities in...

Revvity Signals handles all software development, allowing researchers to explore new drug therapies. Learn how our cloud-native...

Artificial intelligence (AI) and machine learning (ML) are revolutionizing the cybersecurity space. Learn how Revvity Signals...

Signals DLX can integrate any lab instrument or application with Signals Notebook. Learn how this provides more time for science...

PROTAC technology and TPD research present many opportunities in drug discovery. Learn how Signals Research Suite provides a...

Signals Research Suite has RNA specific tools for leading biopharmaceutical companies to make data-driven decisions. Learn how...

Revvity Signals offers AI solutions for R&D scientists and researchers. Learn how Signals Research Suite supports AI...

Revvity Signals helps take advantage of AI-ready data within antibody drug discovery. Learn how Signals Research Suite can help...